Submit Your Feeds

Business News • PR NewsWire • BioInvent to Host Key Opinion Leader Call on Enhancing Checkpoint Inhibitors for the Treatment of Solid Cancers

BioInvent to Host Key Opinion Leader Call on Enhancing Checkpoint Inhibitors for the Treatment of Solid Cancers
BioInvent to Host Key Opinion Leader Call on Enhancing Checkpoint Inhibitors for the Treatment of Solid Cancers

LUND, Sweden, July 13, 2020 /PRNewswire/ -- Call & Webcast on Tuesday, July 21 at 10 a.m. Eastern Time BioInvent International AB ("BioInvent" or the "Company") (OMXS: BINV) ), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory...

View More : https://www.prnewswire.com:443/news-releases/bioinvent-to-host-key-opinion-leader-call-on-enhancing-checkpoint-inhibitor...
Releted News by prnewswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds CDXC and WLTW Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds TORC and GCAP Shareholders About Its Ongoing Investigations
Growatt introduces new generation three-phase inverter into Brazilian market
BioInvent to Host Key Opinion Leader Call on Enhancing Checkpoint Inhibitors for the Treatment of Solid Cancers
ICIS anuncia aquisição da Chemical Data (CDI)
ICIS anuncia la adquisición de Chemical Data (CDI)
Home Sitemap Contact Us
© businessNewsNewsNews.com